Instil Bio
98 hedge funds and large institutions have $551M invested in Instil Bio in 2022 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 7 closing their positions.
314% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 7
68% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 19
26% more funds holding
Funds holding: 78 → 98 (+20)
0.04% more ownership
Funds ownership: 4.57% → 4.61% (+0.04%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
57% less capital invested
Capital invested by funds: $1.27B → $551M (-$717M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$19.8M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$8.93M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.87M |
| 4 |
BlackRock
New York
|
+$5.94M |
| 5 |
Renaissance Technologies
New York
|
+$2.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$25.6M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$21M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.28M |
| 4 |
VA
VR Adviser
New York
|
-$6.14M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$2.26M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TFO
101
Tarbox Family Office
Newport Beach,
California
| – | -$1K | -6 | Closed |
|
102
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | +$142 | +1 | New |
|
|
CS
103
Credit Suisse
Zurich,
Switzerland
| – | +$425 | +3 | New |
|
TIL Hedge Fund Activity: Q2 2022 in Review
98 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q2 2022, worth a combined $551M — down 57% from $1.27B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new TIL positions and 7 closed out — a net gain of 22 holders — while 32 added to existing stakes and 19 trimmed.
The largest buyer was RA Capital Management, adding an estimated $19.8M. The largest seller was HHLR Advisors, exiting entirely with an estimated $25.6M sold.
- 98 institutional investors held Instil Bio (TIL) as of Q2 2022, up from 78 in Q1 2022.
- Funds reported $551M of Instil Bio stock for Q2 2022, down 57% quarter-over-quarter.
- 29 funds opened new Instil Bio positions in Q2 2022 and 7 closed out, a net change of +22 holders.
- The largest Instil Bio buyer in Q2 2022 was RA Capital Management, an estimated $19.8M added.
- The largest Instil Bio seller in Q2 2022 was HHLR Advisors, an estimated $25.6M sold.
Based on aggregated 13F filings for Q2 2022.